Changes in endogenous monoamines in aged rats

J. J. Lee, C. K. Chang, I. M. Liu, T. C. Chi, H. J. Yu, J. T. Cheng

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

1. It has been documented that ageing may alter endogenous neurotransmitters. However, these results are controversial. Thus, in the present study, cerebral cortex and plasma from male Wistar rats aged 8 weeks and 6, 12 or 24 months were used to investigate the changes in monoamines using electrochemical detection. 2. A marked decrease in L-dihydroxyphenylalanine (L-DOPA) was observed in aged rats. Like the decrease in dopamine (DA), levels of 5-hydroxytryptamine (5-HT) and 5-hydroxyindolacetic acid (5-HIAA), the major metabolite of 5-HT, in aged rats were decreased in the cerebral cortex and plasma. Plasma levels of noradrenaline and levels of adrenaline in the cerebral cortex were also decreased in aged rats. Moreover, levels of 3,4-dihydroxyphenylacetic acid (DOPAC), a metabolite of DA, in the cerebral cortex and plasma were reduced by ageing. The level of homovanillic acid (HVA) in all samples was markedly increased with ageing. 3. The ratio of DOPAC/DA and 5-HIAA/5-HT, being closely linked with the activity of monoamine oxidase, was increased in the cerebral cortex and plasma with ageing. The ratio of HVA/DOPAC, an index of the activity of catechol-O-methyltransferase, was also higher in the cerebral cortex and plasma of aged rats. 4. These data suggest that ageing may alter endogenous monoamines in both the brain and peripheral tissues.

Original languageEnglish
Pages (from-to)285-289
Number of pages5
JournalClinical and Experimental Pharmacology and Physiology
Volume28
Issue number4
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Cerebral Cortex
Dopamine
Serotonin
Homovanillic Acid
Acids
Catechol O-Methyltransferase
3,4-Dihydroxyphenylacetic Acid
Dihydroxyphenylalanine
Monoamine Oxidase
Epinephrine
Neurotransmitter Agents
Wistar Rats
Norepinephrine
Brain

Keywords

  • Ageing
  • Catechol-O-methyltransferase
  • High-pressure liquid chromatography-electrochemical detection
  • Monoamine
  • Monoamine oxidase

ASJC Scopus subject areas

  • Physiology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Changes in endogenous monoamines in aged rats. / Lee, J. J.; Chang, C. K.; Liu, I. M.; Chi, T. C.; Yu, H. J.; Cheng, J. T.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 28, No. 4, 2001, p. 285-289.

Research output: Contribution to journalArticle

Lee, J. J. ; Chang, C. K. ; Liu, I. M. ; Chi, T. C. ; Yu, H. J. ; Cheng, J. T. / Changes in endogenous monoamines in aged rats. In: Clinical and Experimental Pharmacology and Physiology. 2001 ; Vol. 28, No. 4. pp. 285-289.
@article{3bb0d4b05c934b45acede5021bf62956,
title = "Changes in endogenous monoamines in aged rats",
abstract = "1. It has been documented that ageing may alter endogenous neurotransmitters. However, these results are controversial. Thus, in the present study, cerebral cortex and plasma from male Wistar rats aged 8 weeks and 6, 12 or 24 months were used to investigate the changes in monoamines using electrochemical detection. 2. A marked decrease in L-dihydroxyphenylalanine (L-DOPA) was observed in aged rats. Like the decrease in dopamine (DA), levels of 5-hydroxytryptamine (5-HT) and 5-hydroxyindolacetic acid (5-HIAA), the major metabolite of 5-HT, in aged rats were decreased in the cerebral cortex and plasma. Plasma levels of noradrenaline and levels of adrenaline in the cerebral cortex were also decreased in aged rats. Moreover, levels of 3,4-dihydroxyphenylacetic acid (DOPAC), a metabolite of DA, in the cerebral cortex and plasma were reduced by ageing. The level of homovanillic acid (HVA) in all samples was markedly increased with ageing. 3. The ratio of DOPAC/DA and 5-HIAA/5-HT, being closely linked with the activity of monoamine oxidase, was increased in the cerebral cortex and plasma with ageing. The ratio of HVA/DOPAC, an index of the activity of catechol-O-methyltransferase, was also higher in the cerebral cortex and plasma of aged rats. 4. These data suggest that ageing may alter endogenous monoamines in both the brain and peripheral tissues.",
keywords = "Ageing, Catechol-O-methyltransferase, High-pressure liquid chromatography-electrochemical detection, Monoamine, Monoamine oxidase",
author = "Lee, {J. J.} and Chang, {C. K.} and Liu, {I. M.} and Chi, {T. C.} and Yu, {H. J.} and Cheng, {J. T.}",
year = "2001",
doi = "10.1046/j.1440-1681.2001.03439.x",
language = "English",
volume = "28",
pages = "285--289",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Changes in endogenous monoamines in aged rats

AU - Lee, J. J.

AU - Chang, C. K.

AU - Liu, I. M.

AU - Chi, T. C.

AU - Yu, H. J.

AU - Cheng, J. T.

PY - 2001

Y1 - 2001

N2 - 1. It has been documented that ageing may alter endogenous neurotransmitters. However, these results are controversial. Thus, in the present study, cerebral cortex and plasma from male Wistar rats aged 8 weeks and 6, 12 or 24 months were used to investigate the changes in monoamines using electrochemical detection. 2. A marked decrease in L-dihydroxyphenylalanine (L-DOPA) was observed in aged rats. Like the decrease in dopamine (DA), levels of 5-hydroxytryptamine (5-HT) and 5-hydroxyindolacetic acid (5-HIAA), the major metabolite of 5-HT, in aged rats were decreased in the cerebral cortex and plasma. Plasma levels of noradrenaline and levels of adrenaline in the cerebral cortex were also decreased in aged rats. Moreover, levels of 3,4-dihydroxyphenylacetic acid (DOPAC), a metabolite of DA, in the cerebral cortex and plasma were reduced by ageing. The level of homovanillic acid (HVA) in all samples was markedly increased with ageing. 3. The ratio of DOPAC/DA and 5-HIAA/5-HT, being closely linked with the activity of monoamine oxidase, was increased in the cerebral cortex and plasma with ageing. The ratio of HVA/DOPAC, an index of the activity of catechol-O-methyltransferase, was also higher in the cerebral cortex and plasma of aged rats. 4. These data suggest that ageing may alter endogenous monoamines in both the brain and peripheral tissues.

AB - 1. It has been documented that ageing may alter endogenous neurotransmitters. However, these results are controversial. Thus, in the present study, cerebral cortex and plasma from male Wistar rats aged 8 weeks and 6, 12 or 24 months were used to investigate the changes in monoamines using electrochemical detection. 2. A marked decrease in L-dihydroxyphenylalanine (L-DOPA) was observed in aged rats. Like the decrease in dopamine (DA), levels of 5-hydroxytryptamine (5-HT) and 5-hydroxyindolacetic acid (5-HIAA), the major metabolite of 5-HT, in aged rats were decreased in the cerebral cortex and plasma. Plasma levels of noradrenaline and levels of adrenaline in the cerebral cortex were also decreased in aged rats. Moreover, levels of 3,4-dihydroxyphenylacetic acid (DOPAC), a metabolite of DA, in the cerebral cortex and plasma were reduced by ageing. The level of homovanillic acid (HVA) in all samples was markedly increased with ageing. 3. The ratio of DOPAC/DA and 5-HIAA/5-HT, being closely linked with the activity of monoamine oxidase, was increased in the cerebral cortex and plasma with ageing. The ratio of HVA/DOPAC, an index of the activity of catechol-O-methyltransferase, was also higher in the cerebral cortex and plasma of aged rats. 4. These data suggest that ageing may alter endogenous monoamines in both the brain and peripheral tissues.

KW - Ageing

KW - Catechol-O-methyltransferase

KW - High-pressure liquid chromatography-electrochemical detection

KW - Monoamine

KW - Monoamine oxidase

UR - http://www.scopus.com/inward/record.url?scp=0035091645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035091645&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1681.2001.03439.x

DO - 10.1046/j.1440-1681.2001.03439.x

M3 - Article

C2 - 11251641

AN - SCOPUS:0035091645

VL - 28

SP - 285

EP - 289

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 4

ER -